# US 2025/0326786 A1 · Systems and methods for preparing a polypeptide from a mixture

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0326786 A1
- Document ID: US20250326786A1
- Status: Published application
- Kind: A1
- Application number: 19/255,580
- Filed: 2025-06-30
- Published: 2025-10-23
- Earliest claimed: 2018-07-02
- Assignees: Regeneron Pharmaceuticals, Inc.
- Applicants: Regeneron Pharmaceuticals, Inc.
- Inventors: Isabelle LIVIGNI; Stefanie MCDERMOTT; James REILLY; John MATTILA
- Web page: https://patentgrep.com/patent/US20250326786A1

## CPC

- C07K 1/1077: {by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids}
- B01D 15/1864: {using two or more columns}
- B01D 15/305: {Hydrophilic interaction chromatography [HILIC]}
- C07K 1/20: Partition-, reverse-phase or hydrophobic interaction chromatography
- C07K 1/36: by a combination of two or more processes of different types
- C07K 16/065: {Purification, fragmentation}
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- B01D: SEPARATION (separating solids from solids by wet methods B03B, B03D; by pneumatic jigs or tables B03B; by other dry methods B07; magnetic or electrostatic separation of solid materials from solid materials or fluids, separation by high-voltage electric fields B03C; centrifuges, vortex apparatus B04; presses per se for squeezing-out liquid from liquid-containing material B30B9/02; treatment of water C02F, e.g. softening by ion-exchange C02F1/42; {arrangements of air intake cleaners in gas turbine plants F02C7/05} ; arrangements or mounting of filters in air-conditioning, air-humidification or ventilation F24F13/28)

## Abstract

Embodiments of the present disclosure are directed to methods for preparing a target polypeptide from a mixture including the target polypeptide. The method may include contacting the mixture to a hydrophobic interaction chromatography (HIC) apparatus including multiple chromatographic zones. The method may further include passing the target polypeptide through the outlets of at least a first zone and a second zone of the HIC apparatus. A residence time for the mixture including the target polypeptide in a first zone may be approximately the same as a residence time of one or more mobile phases in the second zone.

## Claims

### Claim at position 1

1-20. (canceled)

### Claim 21

A method for preparing a target polypeptide from a mixture including the target polypeptide, the method comprising:
introducing the mixture including the target polypeptide to a first column;
passing a first effluent including the target polypeptide from the first column to a second column;
introducing the mixture including the target polypeptide to a third column;
passing a second effluent including the target polypeptide from the third column to a fourth column; and
introducing one or more mobile phases to the fourth column;
wherein a sum of a residence time of the mixture including the target polypeptide in the first column and a residence time of the first effluent including the target polypeptide in the second column is substantially the same as a residence time of the one or more mobile phases in the fourth column.

### Claim 22 (depends on 21)

The method of claim 21, wherein the mixture includes a first concentration of an impurity, the first effluent includes a second concentration of the impurity, and the second concentration is less than the first concentration.

### Claim 23 (depends on 21)

The method of claim 21, further comprising introducing one or more mobile phases to the first column, wherein a sum of a residence time of the mixture including the target polypeptide in the third column and a residence time of the second effluent in the fourth column is substantially the same as a residence time of the one or more mobile phases in the first column.

### Claim 24 (depends on 21)

The method of claim 21, wherein the target polypeptide includes an antibody.

### Claim 25 (depends on 24)

The method of claim 24, wherein the antibody is a monoclonal antibody having a molecular weight of 130 kDa to 200 kDa.

### Claim 26 (depends on 24)

The method of claim 24, wherein the antibody is a monoclonal antibody having a molecular weight of about 140 kDa to about 150 kDa.

### Claim 27 (depends on 24)

The method of claim 24, wherein the antibody is a monoclonal antibody having a molecular weight of 130.5 kDa to 159.5 kDa.

### Claim 28 (depends on 24)

The method of claim 24, wherein the antibody is a monoclonal antibody having a molecular weight of about 140 kDa, about 145 kDa, or about 150 kDa.

### Claim 29 (depends on 21)

The method of claim 21, wherein the target polypeptide includes an Fc-fusion protein.

### Claim 30 (depends on 29)

The method of claim 29, wherein the Fc-fusion protein is a trap protein.

### Claim 31 (depends on 21)

The method of claim 21, wherein the target polypeptide is prepared at a productivity greater than or equal to about 50 g/L·hr, a yield greater than or equal to 80%, and/or a high molecular weight clearance factor greater than or equal to 1.3.

### Claim 32

A method for preparing a target polypeptide from a mixture including the target polypeptide, the method comprising:
contacting the mixture including the target polypeptide to a first zone of a hydrophobic interaction chromatography (HIC) apparatus, the first zone having one or more chromatographic columns and an outlet;
passing an effluent including the target polypeptide from the first zone of the HIC apparatus to a second zone of the HIC apparatus;
contacting one or more mobile phases to the second zone of the HIC apparatus, the second zone having one or more chromatographic columns and an outlet; and
passing the target polypeptide through the outlets of at least the first and second zones of the HIC apparatus;
wherein the mixture includes a first concentration of an impurity, the effluent includes a second concentration of the impurity, and the second concentration is less than the first concentration; and
wherein a residence time for the mixture including the target polypeptide in the first zone is configured to be approximately the same as a residence time of the one or more mobile phases in the second zone.

### Claim 33 (depends on 32)

The method of claim 32, wherein passing one or more mobile phases through the second zone comprises:
passing a wash buffer through the second zone;
passing a stripping buffer through the second zone; and
passing an equilibration buffer through the second zone;
wherein the residence time of the one or more mobile phases in the second zone is equal to a sum of a residence time of the wash buffer in the second zone, a residence time of the stripping buffer in the second zone, and a residence time of the equilibration buffer in the second zone.

### Claim 34 (depends on 33)

The method of claim 33, wherein the wash buffer has a different composition than the equilibration buffer.

### Claim 35 (depends on 32)

The method of claim 32, wherein the effluent is a first effluent, and the method further comprises:
passing a second effluent including the target polypeptide from the second zone of the HIC apparatus through a third zone of the HIC apparatus; and
after the effluent has been passed through the third zone of the HIC apparatus, passing the mixture including the target polypeptide through the third zone of the HIC apparatus.

### Claim 36 (depends on 35)

The method of claim 35, wherein the second effluent is generated by the passing of the mixture including the target polypeptide through the second zone of the HIC apparatus; and
the one or mobile phases are passed through the second zone of the HIC apparatus while the second effluent and the mixture including the target polypeptide are passed through the third zone of the HIC apparatus.

### Claim 37 (depends on 32)

The method of claim 32, wherein one or more of an ultraviolet absorption, electrical conductivity, or pH of a resident solution are measured at an outlet of either the first zone or second zone.

### Claim 38 (depends on 32)

The method of claim 32, wherein the target polypeptide is prepared at a productivity greater than or equal to 50 g/L·hr and the method has a HMW CF of at least approximately 1.3.

### Claim 39 (depends on 32)

The method of claim 32, wherein the first zone or the second zone includes more than one chromatographic column.

### Claim 40 (depends on 32)

The method of claim 32, wherein the target polypeptide includes an antibody.

### Claim 41 (depends on 40)

The method of claim 40, wherein the antibody is a monoclonal antibody having a molecular weight of 130 kDa to 200 kDa.

### Claim 42 (depends on 40)

The method of claim 40, wherein the antibody is a monoclonal antibody having a molecular weight of about 140 kDa to about 150 kDa.

### Claim 43 (depends on 40)

The method of claim 40, wherein the antibody is a monoclonal antibody having a molecular weight of 130.5 kDa to 159.5 kDa.

### Claim 44 (depends on 40)

The method of claim 40, wherein the antibody is a monoclonal antibody having a molecular weight of about 140 kDa, about 145 kDa, or about 150 kDa.

### Claim 45 (depends on 32)

The method of claim 32, wherein the target polypeptide includes an Fc-fusion protein.

### Claim 46 (depends on 45)

The method of claim 45, wherein the Fc-fusion protein is a trap protein.
